| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $214,952,043 ) (Continued on the next page) |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21AI196204 | Targeting Host Factors Essential for EBV Episome Persistence | 000 | 1 | NIH | 2/12/2026 | $224,368 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AI195206 | Molecular determinants and vulnerabilities of HIV-1 spread by cell-to-cell transmission | 000 | 1 | NIH | 2/19/2026 | $713,107 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AG091335 | The Legacy of Childhood SES and Lead Exposure on Dementia Risk: ARIC-NCS Historical Census Linkage | 001 | 1 | NIH | 3/2/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AG091335 | The Legacy of Childhood SES and Lead Exposure on Dementia Risk: ARIC-NCS Historical Census Linkage | 000 | 1 | NIH | 1/30/2026 | $645,743 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AI195876 | Determine how a normal microbial environment protects against autoimmune diabetes | 000 | 1 | NIH | 2/19/2026 | $760,277 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AG082190 | Augmenting AXL and MERTK function to restrain cognitive decline and improve health span in mouse models of Alzheimer's Disease | 000 | 2 | NIH | 3/27/2026 | $707,095 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM162600 | Integrative Structural Biology in Viral RNA Synthesis Machinery | 000 | 1 | NIH | 5/1/2026 | $437,250 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R00AG075255 | Investigating cerebrovascular regulation during exercise as a factor influencing cortical resource engagement for balance control with aging | 000 | 5 | NIH | 2/27/2026 | $248,960 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31HD122353 | Impact of Hyperinsulinemia on Mammary Gland Development and Inflammatory Microenvironment | 000 | 1 | NIH | 5/14/2026 | $41,079 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM159945 | Genetic inference and prediction in diverse, multi-ancestry cohorts | 000 | 2 | NIH | 6/17/2026 | $423,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM159832 | Somatic mosaicism across mouse tissues during different life stages | 000 | 2 | NIH | 5/7/2026 | $423,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21NS143157 | Cerebellum wide imaging of neural activity in freely behaving animals | 000 | 2 | NIH | 3/26/2026 | $221,988 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | T32GM132029 | Training the Next Generation of Chemical Biologists | 000 | 7 | NIH | 6/17/2026 | $467,081 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01EY038606 | CRCNS Data Sharing Proposal: One hundred thousand mental images | 001 | 2 | NIH | 7/1/2026 | $379,778 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R34AT012666 | A Pilot Investigation of a Mobile Application-Enhanced Mindfulness-Based Preventive Intervention Targeting Adolescent Conduct Problems | 000 | 3 | NIH | 5/1/2026 | $232,407 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AA030955 | Impact of prenatal opioid exposure on corticostriatal circuits that modulate alcohol-related behaviors | 000 | 4 | NIH | 5/25/2026 | $534,833 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01DK136237 | Placental Insulin Signaling and mTOR Nutrient-Sensing Programming of Offspring Metabolic Health | 000 | 4 | NIH | 2/16/2026 | $521,795 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R00DA052624 | Nucleus accumbens fast-spiking interneurons regulate opioid reward and addiction | 000 | 5 | NIH | 2/11/2026 | $249,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HD094809 | Newborn Iron Deficiency | 000 | 8 | NIH | 5/25/2026 | $570,468 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21AI190751 | Development of broadly protective Lassa vaccines using the Pichinde virus vector | 000 | 1 | NIH | 4/9/2026 | $192,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | T32DE036162 | Minnesota Dental, Oral and Craniofacial Training in Research | 000 | 1 | NIH | 7/3/2026 | $405,911 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HD117850 | Thyroid Hormone as a Key Regulator of Neurodevelopment during Early Life Iron Deficiency | 000 | 2 | NIH | 6/15/2026 | $659,035 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161293 | Cell Context and Variant Effects: Multiplexed Assays for Synthetic Protein Innovation | 000 | 1 | NIH | 3/19/2026 | $492,931 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161202 | Dynamics of Motile Flagella in Fluid Media | 000 | 1 | NIH | 3/19/2026 | $373,737 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31DK146624 | Elucidating the role of ketone bodies in hepatic PUFA homeostasis and MASLD-MASH progression | 000 | 1 | NIH | 3/19/2026 | $35,783 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31DK146624 | Elucidating the role of ketone bodies in hepatic PUFA homeostasis and MASLD-MASH progression | 001 | 1 | NIH | 3/19/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21CA310158 | Therapeutic Restoration of Cholangiocyte Primary Cilia via Microbiota-Derived Butyrate: A Novel Approach for Bile Duct Cancer | 000 | 1 | NIH | 4/9/2026 | $408,829 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA314164 | Primary Cilia as Metabolic Regulators in Cholangiocyte Health and Disease | 000 | 1 | NIH | 7/3/2026 | $626,943 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HL180774 | Evolving extracellular matrices evoke signaling pathways that govern cardiomyocyte maturation | 000 | 1 | NIH | 7/3/2026 | $543,957 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161467 | A comprehensive analytical framework for multi-source, multi-way, and multi-cohort data | 000 | 1 | NIH | 2/27/2026 | $333,290 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | K23DK146162 | Technology-Enhanced Adherence to Medication intervention for youth with Type 2 Diabetes (TEAM-T2D) | 000 | 1 | NIH | 3/19/2026 | $177,877 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R00DA060895 | Mapping the Functional and Anatomical Pathways from the Anterior and Posterior Paraventricular Nucleus of the Thalamus to the Nucleus Accumbens: Implications for Opioid Use | 000 | 2 | NIH | 2/18/2026 | $249,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | P01AI198498 | Exploiting virus and host diversity to define mechanisms of cross-species infections | 000 | 1 | NIH | 6/30/2026 | $2,000,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM166076 | Advancing Mass Spectrometry Platforms for Next-Generation Biotherapeutics: Antibodies, AAVs, and RNA Therapeutics | 000 | 1 | NIH | 6/22/2026 | $423,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | S10OD040074 | A next-generation mass spectrometry system for advancing quantitative proteome science in the Upper Midwest region | 000 | 1 | NIH | 7/2/2026 | $1,735,621 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | S10OD040074 | A next-generation mass spectrometry system for advancing quantitative proteome science in the Upper Midwest region | 000 | 1 | NIH | 7/2/2026 | $1 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31NS149569 | Seizure frequency reduction through Bayesian-optimized cerebellar stimulation and perturbation-based risk modeling | 000 | 1 | NIH | 5/7/2026 | $37,548 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161283 | TERPENE: Titer Enhancement via Refactored Precursor pathways for Natural Produce Discovery | 000 | 1 | NIH | 5/7/2026 | $423,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AI200568 | Engineering Immunocompetent Human Tissues to Define Inflammatory State Transitions | 000 | 1 | NIH | 6/30/2026 | $2,946,564 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31NS149569 | Seizure frequency reduction through Bayesian-optimized cerebellar stimulation and perturbation-based risk modeling | 001 | 1 | NIH | 5/7/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31AI194928 | Engineering Adeno-associated virus vectors for the in vivo generation of CAR T cells targeting HIV B cell reservoirs | 000 | 1 | NIH | 5/12/2026 | $35,951 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30AI197932 | Development and Implementation of a Cost-Effective Diagnostic Algorithm to Reduce AIDS-Related Deaths among Hospitalized People with Advanced HIV Disease | 000 | 1 | NIH | 5/6/2026 | $55,114 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AI189558 | Defining the Mechanism of Intoxication of the Clostridioides difficile Transferase | 000 | 1 | NIH | 2/19/2026 | $529,512 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21CA313195 | Single-Cell Signaling Network Profiling of Pooled CRISPR Screens by Mass Cytometry | 000 | 1 | NIH | 5/7/2026 | $406,325 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F32HL186726 | Novel therapeutic and spatial proteomics approaches to determine macrophage-fibroblast cross-talk during chronic GVHD | 000 | 1 | NIH | 7/7/2026 | $79,348 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01EB038654 | Technology Development for Whole Brain Functional and Structural Connectivity Mapping at 10.5T | 000 | 1 | NIH | 4/10/2026 | $531,021 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01EB038780 | Dual density-dependent molecular AND gates: ultraselective bispecific targeting via avidity | 000 | 1 | NIH | 4/10/2026 | $471,967 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01MH138850 | Precise Functional Characterization of the Developing Infant Brain using a Clinical 7T MRI Scanner | 000 | 1 | NIH | 7/6/2026 | $615,444 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01EB038350 | Safe, effective, and trustworthy AI for healthcare delivery organizations and populations across the United States | 000 | 1 | NIH | 3/30/2026 | $654,117 |
|
